Bringing forward reperfusion with oxygenated blood perfusion beyond arterial occlusion during endovascular procedures in patients with acute ischemic stroke.
OBJECTIVE
High recanalization rates achieved with endovascular procedures are not always followed by the expected clinical improvement. These time-consuming procedures imply a delayed reperfusion despite the capacity of earlier intravascular microcatheter bypass to the ischemic tissue beyond the clot. We aimed to explore the safety and feasibility of MOB beyond the clot.


METHODS
We studied patients with stroke undergoing endovascular procedures. The timing of procedural steps was recorded. We then explored the safety and feasibility of repeated femoral artery MOB injections beyond the occlusion every time the clot was crossed in 17 patients. Pre- and postocclusion flow was continuously monitored with TCD.


RESULTS
We studied 60 patients (mean age, 70 ± 11 years; median NIHSS score, 20; IR, 18-21). Of them, 33 (55%) received IV-tPA before the endovascular procedure. The following arteries were occluded: the MCA (63.3%, n = 38) and the ICA (36.6%, n = 22). The TSO to arterial puncture was 193 ± 77 minutes. The occluding clot was successfully crossed with the microcatheter in 46 patients (76.6%; mean TSO, 228 ± 82 minutes). Recanalization was achieved in 44 patients (73.2%; mean TSO, 328 ± 144 minutes). Repeated MOB injections were performed in 17 patients. Patients with/without MOB presented with similar baseline characteristics. The median number of MOB injections was 2 (IR, 2-3), and the median injected blood volume was 40 mL (IR, 27.5-50). The mean time from first MOB to arterial recanalization was 136 ± 86 minutes. During MOB, a nonpulsatile flow appeared in previously nonvisible distal branches on TCD.


CONCLUSIONS
In this small series, oxygenated blood delivered through a microcatheter positioned distal to the site of occlusion was feasible and safe. Until final recanalization is achieved, MOB injections may generate intermittent reperfusion for up to 2 hours.
Ribo
M
M
Hospital Vall d'Hebron, Barcelona, Spain. marcriboj@hotmail.com
Rubiera
M
M
Pagola
J
J
Rodriguez-Luna
D
D
Meler
P
P
Flores
A
A
Alvarez-Sabin
J
J
Molina
C A
CA
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D002545:Brain Ischemia / Q000503:physiopathology / Q000628:therapy*; D002404:Catheterization / Q000295:instrumentation / Q000379:methods; D002560:Cerebrovascular Circulation / Q000502:physiology*; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D005260:Female; D005263:Femoral Artery; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008904:Miniaturization; D010100:Oxygen / Q000097:blood*; D015424:Reperfusion / Q000295:instrumentation / Q000379:methods*; D015912:Thrombolytic Therapy
D010100:Oxygen
Stroke. 1992 May;23(5):632-40
1579958
Stroke. 1988 Apr;19(4):512-7
2896402
Stroke. 2008 Apr;39(4):1205-12
18309168
Stroke. 2001 May;32(5):1079-84
11340213
Stroke. 2010 Apr;41(4):695-9
20167923
Stroke. 2007 Jul;38(7):2127-35
17525387
Stroke. 2008 Dec;39(12):3283-7
18772441
Circulation. 1987 Jul;76(1):142-54
3109764
Stroke. 2006 Jan;37(1):263-6
16339467
N Engl J Med. 1995 Dec 14;333(24):1581-7
7477192
Stroke. 2002 Sep;33(9):2197-203
12215587
Stroke. 2009 Aug;40(8):2761-8
19590057
N Engl J Med. 2008 Sep 25;359(13):1317-29
18815396
Neuroradiology. 2004 Nov;46(11):923-34
15551092
Neuroradiology. 2007 Feb;49(2):93-102
17177065
J Neuroimaging. 2009 Apr;19(2):188-90
18800999
Stroke. 2006 Apr;37(4):1000-4
16514102